Devices › Catheter, embolectomy
Device brand name · Embolectomy catheter
TufTex Over-the-Wire Embolectomy Catheter: medical device reports filed with FDA
361 reports name it, 2022–2026. Manufacturer given most often on reports: Lemaitre Vascular. Product code DXE.
- 361
- device reports naming the brand
- 0% of all MAUDE reports · about 80 a year
- 159
- reports, 12 months to August 2026
- 88 in the 12 months before
- 99.7%
- classified as malfunction
- 80.1% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
361 medical device reports received by FDA name the brand "TufTex Over-the-Wire Embolectomy Catheter" (embolectomy catheter); the manufacturer given most often on reports is Lemaitre Vascular; received from January 2022 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
159 reports arrived in the 12 months to August 2026, up 81% from 88 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (99.7%) and injury (0.3%); across all catheter, embolectomy reports (product code DXE) death is recorded in 1.8% and malfunction in 80.1%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are material rupture (89.8%), failure to deflate (5%) and inflation problem (1.4%). The patient problems coded most often are administration site reaction. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 7,789 reports carrying product code DXE. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Material rupture | 324 | 89.8% | 11.8% |
| Failure to deflate | 18 | 5% | 1.1% |
| Inflation problem | 5 | 1.4% | 0.9% |
| Deflation problem | 4 | 1.1% | 3.9% |
| Manufacturing, packaging or shipping problem | 4 | 1.1% | 0.1% |
| Leak/splashthe device leaked | 3 | 0.8% | 2.6% |
| Material separation | 3 | 0.8% | 5.7% |
| Detachment of device or device componentpart of the device came off | 2 | 0.6% | 3.8% |
| Material deformation | 2 | 0.6% | 6% |
| Breakthe device broke | 1 | 0.3% | 12.7% |
| Incomplete or missing packaging | 1 | 0.3% | 0% |
| Material split, cut or torn | 1 | 0.3% | 0.3% |
| Packaging problem | 1 | 0.3% | 0% |
| Separation problem | 1 | 0.3% | 0.1% |
| Stretched | 1 | 0.3% | 0.8% |
| Unraveled material | 1 | 0.3% | 0.4% |
| Unsealed device packaging | 1 | 0.3% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Administration site reaction | 1 | 0.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | TufTex Over-the-Wire Embolectomy Catheter | Product code DXE | All MAUDE reports |
|---|---|---|---|
| Reports | 361 | 7,789 | 26,136,888 |
| Share of that pool | — | 4.6% | 0% |
| Classified as death, per 1,000 reports | 0 | 18 | 9 |
| Classified as injury | 0.3% | 14.4% | 36.2% |
| Classified as malfunction | 99.7% | 80.1% | 62.3% |
| Filed by the manufacturer | 100% | 93% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code DXE
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Fogarty Arterial Embolectomy Catheter | 1,165 | 37 | 0.2% |
| AngioJet SOLENT omni | 671 | 26 | 1.3% |
| Fogarty Thru-Lumen Embolectomy Catheter | 427 | 76 | 0.7% |
| Indigo System Aspiration Catheter 6 | 472 | 0 | 0% |
| Angiojet Zelantedvt | 304 | 0 | 5.3% |
| Indigo System Aspiration Catheter 8 | 196 | 2 | 1.5% |
| Indigo System Separator 8 | 157 | 4 | 1.9% |
| Indigo System Catrx Aspiration Catheter | 259 | 11 | 0% |
| AngioJet SOLENT Proxi | 175 | 5 | 4.6% |
| AdvanCE | 220 | 8 | 2.7% |
| Pruitt F3 Carotid Shunt | 395 | 73 | 0.3% |
| Internal Hex Implant | 2,074 | 0 | 0% |
| Galileo | 701 | 0 | 0.1% |
| Penumbra System Jet7 Reperfusion Catheter | 379 | 0 | 4% |
| Ruby Coil | 3,360 | 26 | 0.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about TufTex Over-the-Wire Embolectomy Catheter reports
How many FDA reports name TufTex Over-the-Wire Embolectomy Catheter?
361 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 159 in the latest 12 months.
What kinds of events are reported?
malfunction (99.7%) and injury (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
material rupture (89.8%), failure to deflate (5%), inflation problem (1.4%), deflation problem (1.1%) and manufacturing, packaging or shipping problem (1.1%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that TufTex Over-the-Wire Embolectomy Catheter was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.